Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma, Nasopharyngeal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT01312311
What this trial is testing

Weekly Docetaxel Plus Cisplatin as the First-line Therapy for Nasopharyngeal Cancer

Who this might be right for
Nasopharyngeal Cancer
Samsung Medical Center 51
Large-scale testing (Phase 3)UnknownNCT05576272
What this trial is testing

A Phase II/III Trial to Evaluate the Efficacy and Safety of QL1706 in Patients With Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Qilu Pharmaceutical Co., Ltd. 460
Testing effectiveness (Phase 2)Study completedNCT00534001
What this trial is testing

Bupropion in Helping Adults Stop Smoking

Who this might be right for
Bladder CancerCervical CancerEsophageal Cancer+8 more
Roswell Park Cancer Institute 95
Large-scale testing (Phase 3)UnknownNCT03656965
What this trial is testing

EBV Positive Nasopharyngeal Carcinoma Treated With Concurrent Chemo-radiotherapy With or Without Anti-Viral Drug

Who this might be right for
Drug Use for Unapproved Schedule
Kuwait Cancer Control Center 50
Testing effectiveness (Phase 2)Study completedNCT00052611
What this trial is testing

Celecoxib in Preventing Cancer in Patients With Oral Leukoplakia and/or Head and Neck Dysplasia

Who this might be right for
Head and Neck Cancer
Dana-Farber Cancer Institute 23
Not applicableUnknownNCT00577057
What this trial is testing

Benefit of Changing Chemoradiotherapy Sequence and Modifying Radiotherapy Schedule for Advanced Nasopharyngeal Cancer

Who this might be right for
Nasopharyngeal Neoplasms
Hospital Authority, Hong Kong 798
Not applicableUnknownNCT05595265
What this trial is testing

Expression of Programmed Death Ligand-1 (PD-L1) in Nasopharyngeal and Hyypopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal and Hypopharyngeal Carcinoma
Sohag University 50
Testing effectiveness (Phase 2)Study completedNCT00301028
What this trial is testing

Cetuximab, Carboplatin, and Paclitaxel Followed by Radiation Therapy, With or Without Cisplatin, in Treating Patients With Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
M.D. Anderson Cancer Center 48
Testing effectiveness (Phase 2)Study completedNCT03283293
What this trial is testing

Target Volume Delineation After NACT in LA-NPCarcinoma Patients Treated With NACT+ CCRT

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 112
Testing effectiveness (Phase 2)UnknownNCT05520814
What this trial is testing

PD-1 Inhibitors Plus Chemoradiotherapy for Metastatic Nasopharyngeal Carcinoma: an Open-label Single-arm, Phase II Trial

Who this might be right for
Nasopharyngeal CarcinomaPD-1 InhibitorsChemoradiotherapy
Sichuan Cancer Hospital and Research Institute 50
Not applicableStudy completedNCT01155609
What this trial is testing

L-lysine in Treating Oral Mucositis in Patients Undergoing Radiation Therapy With or Without Chemotherapy For Head and Neck Cancer

Who this might be right for
MucositisOral Complications of ChemotherapyOral Complications of Radiation Therapy+65 more
University of Washington 10
Early research (Phase 1)WithdrawnNCT00006106
What this trial is testing

ONYX-015 With Cisplatin and Fluorouracil in Treating Patients With Advanced Head and Neck Cancer

Who this might be right for
Lip and Oral Cavity CancerHead and Neck CancerOropharyngeal Cancer
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT00062348
What this trial is testing

Boronophenylalanine-Fructose Complex (BPA-F) and/or Sodium Borocaptate (BSH) Followed By Surgery in Treating Patients With Thyroid Cancer, Head and Neck Cancer, or Liver Metastases

Who this might be right for
Colorectal CancerHead and Neck CancerMetastatic Cancer
European Organisation for Research and Treatment of Cancer - EORTC 27
Testing effectiveness (Phase 2)Ended earlyNCT03544099
What this trial is testing

Pembrolizumab for Nasopharyngeal Carcinoma Patients With Detectable Plasma Epstein-Barr Virus DNA

Who this might be right for
Nasopharyngeal Carcinoma
National Health Research Institutes, Taiwan 2
Testing effectiveness (Phase 2)Study completedNCT00003580
What this trial is testing

Amifostine to Treat Side Effects of Treatment in Patients Receiving Radiation Therapy and Cisplatin for Advanced Head and Neck Cancer

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganHead and Neck CancerOral Complications+1 more
University of Tennessee
Testing effectiveness (Phase 2)Study completedNCT03848286
What this trial is testing

KL-A167 Injection in Recurrent or Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal CarcinomaRecurrent or Metastatic
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 153
Large-scale testing (Phase 3)Study completedNCT00778908
What this trial is testing

Late-Course Accelerated Hyperfractionated IMRT for Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Guangxi Medical University 120
Not applicableNot Yet RecruitingNCT06947759
What this trial is testing

Application of 18F-FDG PET/MRI for Initial Staging in Locally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nuclear MedicineOncology
Taichung Veterans General Hospital 20
Testing effectiveness (Phase 2)Study completedNCT00738868
What this trial is testing

Cetuximab and Stereotactic Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery

Who this might be right for
Head and Neck Cancer
Centre Oscar Lambret 45
Testing effectiveness (Phase 2)Active Not RecruitingNCT05807880
What this trial is testing

Anlotinib, Penpulimab and Capecitabine in Recurrent/Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Neoplasms
Sun Yat-sen University 59
Next Page